Search Results - "Castellani, Paul"

Sorafenib: Experience and Better Manage­ment of Side Effects Improve Overall Survival in Hepatocellular Carcinoma Patients: A Real-Life Retrospective Analysis by Raoul, Jean-Luc, Adhoute, Xavier, Penaranda, Guillaume, Perrier, Hervé, Castellani, Paul, Oules, Valérie, Bourlière, Marc

“…Background: Sorafenib is the first-line treatment for advanced hepatocellular carcinoma (HCC). The management of its side effects is improving. This study…”
Get full text

Sofosbuvir, velpatasvir and voxilaprevir: a new triple combination for hepatitis C virus treatment. One pill fits all? Is it the end of the road? by Bourlière, Marc, Pietri, Olivia, Castellani, Paul, Oules, Valérie, Adhoute, Xavier

“…The advent of oral direct-acting antiviral agents (DAAs) has dramatically improved the hepatitis C virus (HCV) treatment landscape in the last 4 years,…”
Get full text

Usefulness of staging systems and prognostic scores for hepatocellular carcinoma treatments by Adhoute, Xavier, Penaranda, Guillaume, Raoul, Jean Luc, Le Treut, Patrice, Bollon, Emilie, Hardwigsen, Jean, Castellani, Paul, Perrier, Hervé, Bourlière, Marc

“…Therapeutic management of hepatocellular carcinoma(HCC) is quite complex owing to the underlying cirrhosis and portal vein hypertension. Different scores or…”
Get full text

Double guidewire endoscopic technique, a major evolution in endoscopic retrograde cholangiopancreatography: Results of a retrospective study with historical controls comparing two therapeutic sequential strategies by Laquiere, Arthur, Desilets, Etienne, Belle, Arthur, Castellani, Paul, Grandval, Philippe, Laugier, René, Penaranda, Guillaume, Lecomte, Laurence, Boustiere, Christian

“…Background and Aim Endoscopic access to the common bile duct (CBD) remains difficult in 10% of cases, requiring alternative techniques .CBD access was…”
Get full text

Natural presence of substitution R155K within hepatitis C virus NS3 protease from a treatment‐naïve chronically infected patient by Colson, Philippe, Brouk, Nabil, Lembo, Frédérique, Castellani, Paul, Tamalet, Catherine, Gérolami, René

Get full text

Detection of IL28B SNP DNA from buccal epithelial cells, small amounts of serum, and dried blood spots by Halfon, Philippe, Ouzan, Denis, Khiri, Hacène, Pénaranda, Guillaume, Castellani, Paul, Oulès, Valerie, Kahloun, Asma, Amrani, Nolwenn, Fanteria, Lise, Martineau, Agnès, Naldi, Lou, Bourlière, Marc

“…Point mutations in the coding region of the interleukin 28 gene (rs12979860) have recently been identified for predicting the outcome of treatment of hepatitis…”
Get full text

Retreatment with TACE: The ABCR SCORE, an aid to the decision-making process by Adhoute, Xavier, Penaranda, Guillaume, Naude, Sebastien, Raoul, Jean Luc, Perrier, Herve, Bayle, Olivier, Monnet, Olivier, Beaurain, Patrick, Bazin, Christophe, Pol, Bernard, Folgoc, Gaelle Le, Castellani, Paul, Bronowicki, Jean Pierre, Bourlière, Marc

“…Background & Aims Transarterial chemoembolization (TACE) is the standard of care for intermediate stage hepatocellular carcinoma (HCC) and it is the most…”
Get full text

Management of portal hypertension in patients treated with atezolizumab and bevacizumab for hepatocellular carcinoma by Ollivier-Hourmand, Isabelle, Allaire, Manon, Cervoni, Jean Paul, Weil, Delphine, Ozenne, Violaine, Rautou, Pierre Emmanuel, Bouzbib, Charlotte, Sidali, Sabrina, Oberti, Frédéric, Guillaume, Maeva, Castellani, Paul, Calame, Paul, Barge, Sandrine, Bureau, Christophe

Get full text

Outcomes and safety of atezolizumab plus bevacizumab in the treatment of hepatocellular carcinoma: treatment prognosis and comparison with tyrosine kinase inhibitors in a French multicenter matched real-life study by Adhoute, Xavier, Gonzalez, Alexia, Levi-Strauss, Thomas, Mineur, Laurent, Pénaranda, Guillaume, Sellier, Floriane, Toullec, Clémence, Pietri, Olivia, Castellani, Paul, Tran, Albert, Perrier, Hervé, Bourliere, Marc, Anty, Rodolphe

“…The combination of atezolizumab plus bevacizumab (Atz/Bev) has radically changed the treatment strategy for advanced hepatocellular carcinoma (HCC) but raises…”
Get full text

HCV screening in a tertiary french hospital: just do it by Si Ahmed, Si Nafa, Benali, Souad, Madau, Magalie, Kibeche, Rania, Albenois, Romain, Ghez, Michaël, Belasri, Ines, Hernandez, Christine, Ramirez, Paola, Negre, Julien, Lecomte, Laurence, Sellier, Floriane, Pietri, Olivia, Castellani, Paul, Adhoute, Xavier, Bourliere, Marc

Get full text

Double Guidewire Endoscopic Technique, a Major Evolution in Endoscopic Retrograde Cholangiopancreatography: Results of a Retrospective Study with Historical Controls Comparing Two Therapeutic Sequential Strategies by Desilets, Etienne, Laquière, Arthur, Belle, Arthur, Castellani, Paul, Grandval, Philippe, Laugier, René, Lecompte, Laurence, Boustière, Christian

Get full text

Tu1500 - Double Guidewire Endoscopic Technique, a Major Evolution in Endoscopic Retrograde Cholangiopancreatography: Results of a Retrospective Study with Historical Controls Comparing Two Therapeutic Sequential Strategies by Desilets, Etienne, Laquière, Arthur, Belle, Arthur, Castellani, Paul, Grandval, Philippe, Laugier, René, Lecompte, Laurence, Boustière, Christian

Get full text

Sofosbuvir as backbone of interferon free treatments by Bourlière, Marc, Oules, Valèrie, Ansaldi, Christelle, Adhoute, Xavier, Castellani, Paul

“…Abstract Sofosbuvir is the first-in-class NS5B nucleotide analogues to be launched for hepatitis C virus (HCV) treatment. Its viral potency, pangenotypic…”
Get full text

Hepatocellular carcinoma recurrence in hepatitis C virus-related cirrhosis treated with direct-acting antivirals: a case–control study by Adhoute, Xavier, Penaranda, Guillaume, Raoul, Jean Luc, Sellier, Floriane, Castellani, Paul, Oules, Valerie, Perrier, Herve, Lefolgoc, Gaëlle, Pol, Bernard, Campanile, Manuela, Bayle, Olivier, Beaurain, Patrick, Monnet, Olivier, Bourlière, Marc

“…BACKGROUNDDirect-acting antivirals (DAAs) therapy against hepatitis C viral (HCV) infection has markedly improved the sustained viral response. However, recent…”
Get full text

Prognosis of advanced hepatocellular carcinoma: a new stratification of Barcelona Clinic Liver Cancer stage C: results from a French multicenter study by Adhoute, Xavier, Pénaranda, Guillaume, Raoul, Jean L, Blanc, Jean F, Edeline, Julien, Conroy, Guillaume, Perrier, Hervé, Pol, Bernard, Bayle, Olivier, Monnet, Olivier, Beaurain, Patrick, Muller, Cyril, Castellani, Paul, Bronowicki, Jean-Pierre, Bourlière, Marc

“…BACKGROUNDAdvanced hepatocellular carcinoma (HCC) includes a wide spectrum of tumors and patients’ prognosis after treatment is highly variable. Moreover,…”
Get full text

Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort by Adhoute, Xavier, Pénaranda, Guillaume, Raoul, Jean Luc, Edeline, Julien, Blanc, Jean-Frédéric, Pol, Bernard, Campanile, Manuela, Perrier, Hervé, Bayle, Olivier, Monnet, Olivier, Beaurain, Patrick, Muller, Cyril, Castellani, Paul, Le Treut, Yves Patrice, Bronowicki, Jean Pierre, Bourlière, Marc

“…To compare the performances of the Barcelona clinic liver cancer (BCLC) nomogram and others systems (BCLC, HKLC, CLIP, NIACE) for survival prediction in a…”
Get full text

Recommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system? by Adhoute, Xavier, Penaranda, Guillaume, Castellani, Paul, Perrier, Herve, Bourliere, Marc

“…Several hepatocellular carcinoma (HCC) staging systems have been established, and a variety of country-specific treatment strategies are also proposed. The…”
Get full text

Hepatocellular carcinoma macroscopic gross appearance on imaging: predictor of outcome after transarterial chemoembolization in a real-life multicenter French cohort by Adhoute, Xavier, Pénaranda, Guillaume, Raoul, Jean-Luc, Pietri, Olivia, Bronowicki, Jean-Pierre, Castellani, Paul, Perrier, Hervé, Monnet, Olivier, Bayle, Olivier, Oules, Valérie, Pol, Bernard, Beaurain, Patrick, Muller, Cyrille, Cassagneau, Pierre, Bourlière, Marc

“…BACKGROUNDConventional transarterial chemoembolization (cTACE) with lipiodol is widely performed in patients with hepatocellular carcinoma (HCC) unsuitable for…”
Get full text

Impact of direct-acting antiviral agents on the risk for hepatocellular carcinoma by Adhoute, Xavier, Castellani, Paul, Bourlière, Marc

Get full text

Second-line therapy for advanced hepatocellular carcinoma with regorafenib or cabozantinib: Multicenter French clinical experience in real-life after matching by Adhoute, Xavier, De Matharel, Marie, Mineur, Laurent, Pénaranda, Guillaume, Ouizeman, Dann, Toullec, Clemence, Tran, Albert, Castellani, Paul, Rollet, Armelle, Oules, Valérie, Perrier, Hervé, Si Ahmed, Si Nafa, Bourliere, Marc, Anty, Rodolphe

“…BACKGROUNDStarting a second-line systemic treatment for hepatocellular carcinoma (HCC) is a common situation. The only therapeutic options in France are two…”
Get full text